Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-018509
Filing Date
2011-03-31
Accepted
2011-03-31 06:07:23
Documents
19
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v216517_10k.htm 10-K 1346986
2 v216517_ex10-40.htm EX-10.40 89828
3 GRAPHIC sig1.jpg GRAPHIC 9613
4 GRAPHIC sig2.jpg GRAPHIC 4269
5 v216517_ex10-41.htm EX-10.41 42551
6 v216517_ex10-42.htm EX-10.42 29769
7 v216517_ex10-43.htm EX-10.43 101714
8 v216517_ex10-44.htm EX-10.44 89621
9 GRAPHIC sig3.jpg GRAPHIC 11828
10 v216517_ex10-45.htm EX-10.45 129377
11 GRAPHIC sig4.jpg GRAPHIC 5470
12 GRAPHIC sig5.jpg GRAPHIC 3446
13 v216517_ex10-46.htm EX-10.46 16324
14 GRAPHIC sig6.jpg GRAPHIC 2366
15 GRAPHIC sig7.jpg GRAPHIC 7256
16 v216517_ex21-1.htm EX-21.1 5019
17 v216517_ex31-1.htm EX-31.1 17479
18 v216517_ex31-2.htm EX-31.2 16931
19 v216517_ex32.htm EX-32 5729
  Complete submission text file 0001144204-11-018509.txt   1954331
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28347 | Film No.: 11723689
SIC: 2834 Pharmaceutical Preparations